| Emma Walters Vaimberg, | |
|
500 N Wolfe St, Baltimore, MD 21205-2102 | |
| (203) 247-0031 | |
| Not Available |
| Full Name | Emma Walters Vaimberg |
|---|---|
| Gender | Female |
| Speciality | Student In An Organized Health Care Education/training Program |
| Location | 500 N Wolfe St, Baltimore, Maryland |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053948307 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 3436 (Massachusetts) | Secondary |
| 390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Primary |
| Entity Name | Childrens Health Care Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598869059 PECOS PAC ID: 1355253527 Enrollment ID: O20040216001108 |
News Archive
HemoBioTech announced today the issuance of a new patent US 7,759,306 B2, Methods of Treating Acute Blood Loss. HemoBioTech has an exclusive worldwide license from Texas Tech University to commercialize the technology. The new patent continues to May 16, 2026. The major advance in HemoTech is the presence of Adenosine which has anti-inflammatory activity.
High-density lipoprotein, known colloquially as "good cholesterol", protects against dangerous deposits in the arteries. An important function of HDL is its anti-inflammatory properties. An international research team at the Institute of Innate Immunity at the University Hospital of Bonn and the LIMES Institute at the University of Bonn has identified a central switch by which HDL controls the inflammatory response. The results are presented in the current issue of "Nature Immunology".
Numerous compounds are examined by the National Cancer Institute (NCI) for their potential to prevent or treat cancer. One class of compounds, cyclooxygenase (COX) inhibitors, is currently being tested in both prevention and treatment clinical trials.
Tjada McKenna, deputy coordinator for development for Feed the Future, and Jonathan Shrier, acting special representative for global food security and deputy coordinator for diplomacy for Feed the Future, examine efforts to end global hunger through a "whole-of-government approach" in this article on the initiative's webpage.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Emma Walters Vaimberg, 500 N Wolfe St, Baltimore, MD 21205-2102 Ph: () - | Emma Walters Vaimberg, 500 N Wolfe St, Baltimore, MD 21205-2102 Ph: (203) 247-0031 |
News Archive
HemoBioTech announced today the issuance of a new patent US 7,759,306 B2, Methods of Treating Acute Blood Loss. HemoBioTech has an exclusive worldwide license from Texas Tech University to commercialize the technology. The new patent continues to May 16, 2026. The major advance in HemoTech is the presence of Adenosine which has anti-inflammatory activity.
High-density lipoprotein, known colloquially as "good cholesterol", protects against dangerous deposits in the arteries. An important function of HDL is its anti-inflammatory properties. An international research team at the Institute of Innate Immunity at the University Hospital of Bonn and the LIMES Institute at the University of Bonn has identified a central switch by which HDL controls the inflammatory response. The results are presented in the current issue of "Nature Immunology".
Numerous compounds are examined by the National Cancer Institute (NCI) for their potential to prevent or treat cancer. One class of compounds, cyclooxygenase (COX) inhibitors, is currently being tested in both prevention and treatment clinical trials.
Tjada McKenna, deputy coordinator for development for Feed the Future, and Jonathan Shrier, acting special representative for global food security and deputy coordinator for diplomacy for Feed the Future, examine efforts to end global hunger through a "whole-of-government approach" in this article on the initiative's webpage.
› Verified 7 days ago